Profile
Corporate information
Official name
Celgene Corporation
Registration country
Official name
Celgene Corporation
Registration country
Investment activity status
Active investor
Company type
Biopharmaceutical company committed to improving the lives of patients worldwide.Funding
Funding rounds
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
CHL Medical Partners | Venture capital firm focused on early-stage healthcare sectors. | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
CHL Medical Partners Venture capital firm focused on early-stage healthcare sectors. |
+1 (203) 324-7700 |
N/A |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Armo BioSciences Inc Late-stage immuno-oncology company. |
1 Sep 2017 | Series C-1 Follow-on investment. Round participant. Active |
||
|
Acceleron Pharma Inc Biopharmaceutical company developing protein therapeutics for cancer and orphan diseases. |
United States | 1 Dec 2011 | Series F Initial investment. Round participant. Active |
|
|
Cylene Pharmaceuticals Inc Clinical stage private company developing small molecule drugs against newly validated cancer targets. |
United States | 1 Jan 2007 | Series C Active |
|
|
|
Agios Pharmaceuticals Inc |
United States | N/A |
||
|
|
Gloucester Pharmaceuticals Inc |
United States | N/A |
||
|
|
VentiRx Pharmaceuticals Inc |
United States | N/A |